Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗
Elena Butz, Peggy Sekula(University of Freiburg), Inga Steinbrenner(University of Freiburg), Charlotte Behning(University Hospital Bonn), Anna Köttgen(University of Freiburg), Peter J. Oefner, Helena Hansmann, Elke Schaeffner, Kai-Uwe Eckardt, Wolfram Gronwald(University of Regensburg), Ulla T Schultheiss, Harald Binder(Zimmer Biomet (Netherlands))
University of Regensburg Publication Server (University of Regensburg)
July 16, 2026
Cited by 0
Related Papers
Genome-wide association study of blood pressure and hypertension
|Nature Genetics|2009|1.4k
Evolving importance of kidney disease: from subspecialty to global health burden
|The Lancet|2013|1.2k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
|Nature Genetics|2012|878
New loci associated with kidney function and chronic kidney disease
|Nature Genetics|2010|809